moderna

As COVID-19 continues to circulate, the US Food and Drug Administration (FDA) granted an updated emergency use authorization for the Novavax COVID-19 vaccine on Tuesday. The new vaccine will be available...

The Centers for Disease Control and Prevention on Tuesday recommended that everyone over 6 months old receive the updated COVID-19 shots approved by the Food and Drug Administration on Monday.

A study that put both COVID-19 shots to the test to see which was better for older adults found that the Moderna vaccine was superior.

New data suggest Moderna’s updated COVID booster is more effective against omicron variants … Slightly faster cognitive decline after knee replacement found in people aged 80 and older … Careful...

The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.

Long-term care leaders helping residents secure COVID-19 vaccinations may want to ensure their pharmacy provider has Moderna vaccines on hand after a study found that it was better at protecting residents...

Moderna’s omicron-targeting vaccine provides improved protection, company says … Evusheld found to protect against COVID-19 death in late-stage trial … … FTC to probe pharmacy middlemen’s role...

12 women named Veteran VIPs in McKnight’s Women of Distinction Awards … 3 Moderna shots offer 99% protection against omicron, delta hospitalization … COVID-19 infections fall by 90% from pandemic...

COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.

“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.